Skip To Main Content
Ines Rivero Belenchon on Muck Rack

Ines Rivero Belenchon

As seen in: Nature, Wiley Online Library, Frontiers, MDPI, Dialnet - Universidad de La Rioja
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ines Rivero

Contact Ines Rivero, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Primitive Neuroectodermal Kidney Tumor in Adults. A Systematic Review

|
By Eloisa Gómez, Ines Rivero Belenchon, Ignacio García Verified
| Dialnet - Universidad de La Rioja
Ayuda Buscar en la ayuda Buscar en la ayuda Primitive Neuroectodermal Kidney Tumor in Adults. A Systematic Review Eloísa Cabello-Gómez [1] ; Inés Rivero-Belenchón [1] ; Carmen Belén Congregado-Ruiz [1] ; Ignacio Osmán-García [1] ; Rafael Antonio Medina-López [1] [1] Urology Department, Virgen del Rocío University Hospital, 41013 Sevilla, Spain Localización: Archivos españoles de urología, ISSN 0004-0614, Tomo 79, Nº. 2, 2026, págs.
Open in Who Shared Issue with article?

Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate‐Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence

|
By Laura Castillo, Ines Rivero Belenchon, Ignacio Sanz, UCO Córdoba Spain
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Supporting Information Filename Description pros24910-sup-0001-SUPPLEMENTAL_TABLES_V2.odt17.7 KB SUPPLEMENTAL TABLES. References 1, , , et al., “EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer,” European Urology 79, no. 2 (February 2021): 263–282.
Open in Who Shared Issue with article?

Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review)

|
By Ines Rivero Belenchon, Carmen Saéz, Ignacio García Verified, Rivero Belenchón
| MDPI
1. Introduction Prostate cancer (PCa) is the most common tumor diagnosed in men worldwide, ranking as the third most common cause of cancer death in Europe and the second in the United States [1]. However, PCa is a complex and heterogeneous condition with different degrees of aggressiveness, ranging from indolent to lethal forms [2].
Open in Who Shared Issue with article?
See all 6 articles